Increased arterial inflammation relates to high-risk coronary plaque morphology in HIV-infected patients

Ahmed Tawakol1, Janet Lo, Markella V Zanni

  • 1*Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA; †Program in Nutritional Metabolism, Massachusetts General Hospital and Harvard Medical School, Boston, MA; and ‡Cardiovascular Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.

Insights

Arterial inflammation, measured by F-FDG-PET, is linked to high-risk coronary plaque features in HIV patients with early atherosclerosis. This suggests a potential mechanism for increased cardiovascular disease risk in this population.

Area of Science:

  • Cardiovascular Imaging and Nuclear Medicine
  • Infectious Diseases and Virology
  • Cardiology and Cardiovascular Diseases

Background:

  • HIV infection is associated with an elevated risk of cardiovascular disease (CVD).
  • The underlying mechanisms contributing to this increased CVD risk in HIV-infected individuals are not fully understood.
  • Subclinical coronary atherosclerosis is common in HIV patients on antiretroviral therapy.

Purpose of the Study:

  • To investigate the relationship between arterial inflammation and high-risk coronary plaque characteristics.
  • To assess arterial inflammation using F-FDG-PET and its association with coronary plaque morphology in HIV patients.
  • To explore potential mechanisms linking HIV infection to increased CVD risk.

Main Methods:

  • Forty-one HIV-infected patients with subclinical coronary atherosclerosis were evaluated using F-FDG-PET.
  • Patients were categorized into groups based on aortic target-to-background ratio (TBR), indicating arterial inflammation levels.
  • Coronary CT angiography was used to assess high-risk plaque morphology features.

Main Results:

  • Higher arterial inflammation (higher TBR) in HIV patients correlated with increased prevalence of low-attenuation coronary plaques.
  • Patients with higher TBR showed a greater number of low-attenuation plaques and more vulnerability features in their most diseased plaque.
  • Arterial inflammation remained a significant predictor of low-attenuation plaques, independent of traditional CVD risk factors.

Conclusions:

  • Arterial inflammation, detectable by F-FDG-PET, is associated with high-risk coronary atherosclerotic plaque features in HIV-infected individuals.
  • These findings suggest a potential pathway through which arterial inflammation contributes to CVD risk in the HIV population.
  • Further research is warranted to confirm if arterial inflammation and associated plaque morphology predict clinical CVD events in HIV patients.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
620
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890